Psychiatric comorbidities and suicide risk among users of psychoactive substances
DOI:
https://doi.org/10.17267/2317-3378rec.v9i2.2910Keywords:
Suicide. Drug users. Disorders related to substance use. Mental health.Abstract
OBJECTIVE: To identify the presence of psychiatric comorbidities and risk of suicide in users of psychoactive substances treated at health services. METHODS AND MATERIALS: Descriptive exploratory study carried out with 56 users of psychoactive substances (SPA) in a municipality in the Northwest Mesoregion of the state of Ceará. The data collection instruments were: Self-Reporting Questionnaire (SRQ-20), Depression Assessment Questionnaire (PHQ-9) and the Suicide Rich Index (IRIS). Analysis using descriptive statistics. RESULTS: 78.6% (n = 44) were male, 69.6% (n = 39) single and 66% (n = 39) of the users had children. Of these, 80.4% (n = 45) had positive screening for non-psychotic disorders, 82.1% (n = 46) with depression, 69.7% (n = 39) had a high risk of suicide, with emphasis on presence of a marked recent loss (n = 41; 73.2%) and absent religiosity (n = 29; 51.8%). CONCLUSION: there is a high frequency of psychiatric comorbidities in SPA users, especially non-psychotic disorders and depression. As for the aspects related to the risk of suicide, most were at high risk for such behavior.Downloads
Download data is not yet available.
Downloads
Published
10/23/2020
Issue
Section
Original Articles
How to Cite
1.
Oliveira EN, Melo BT, Moreira RMM, Lira RC, Aragão JMN, Carvalho AG, et al. Psychiatric comorbidities and suicide risk among users of psychoactive substances. Rev Enf Contemp [Internet]. 2020 Oct. 23 [cited 2024 Aug. 24];9(2):202-10. Available from: https://journals.bahiana.edu.br/index.php/enfermagem/article/view/2910